Press Releases

Jul 31, 2019
Axcella Announces Publication of Data Describing Attenuation of Muscle Atrophy with AXA2678 in Short-Term Muscle Disuse Study
Jun 20, 2019
Axcella Health Reports First Quarter 2019 Financial Results and Provides Company Update
May 13, 2019
Axcella Health Announces Closing of Initial Public Offering
May 08, 2019
Axcella Health Announces Pricing of Initial Public Offering
Apr 11, 2019
Axcella Presents Late-Breaker Data Demonstrating Lead AXA™ Candidate AXA1665 Impacted Markers Related to Liver Health
Apr 02, 2019
Axcella Announces Patent Issuance for AXA™ Candidate AXA1125 Methods of Use
Mar 27, 2019
Axcella to Present Late-Breaker Data on Lead AXA™ Candidate, AXA1665 at EASL, the International Liver Congress™
Mar 25, 2019
Axcella Appoints Shreeram Aradhye, M.B.B.S., M.D., as Executive Vice President, Chief Development Officer
Feb 12, 2019
Axcella Announces Patent Issuance for AXA Candidate AXA1125
Jan 24, 2019
Axcella Presents Mechanistic Data Demonstrating that AXA1125 Modulated Liver Metabolic, Inflammatory and Fibrotic Pathways
Displaying 11 - 20 of 21